Evidence map›Paper›PMID 31921672›Full record

ArticleFrontiers in oncology2019

A Case-Control Study of the Association Between the SPP1 Gene SNPs and the Susceptibility to Breast Cancer in Guangxi, China.

Lina Liang, Guanming Lu, Guogang Pan, Yibin Deng, Jiadong Liang, Limei Liang, Jia Liu, Yujin Tang, Guijiang Wei

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Molecular Marker-Assisted Selection ofAnimals : an open access journal from MDPI · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lina LiangDepartment of Medical Laboratory, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Guanming LuDepartment of Breast and Thyroid Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Guogang PanDepartment of Medical Laboratory, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Yibin DengDepartment of Medical Laboratory, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Jiadong LiangDepartment of Medical Laboratory, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Limei LiangDepartment of Medical Laboratory, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Jia LiuDepartment of Spinal Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Yujin TangDepartment of Spinal Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Guijiang WeiDepartment of Medical Laboratory, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Affiliated Hospital of Youjiang Medical University for Nationalities · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secreted phosphoprotein-1 (SPP1) has been reported to be involved in the pathogenesis of breast cancer (BRC), but the influence of SPP1 single nucleotide polymorphisms on the BRC susceptibility has been rarely reported. In this study, we explored the association between rs11730582, rs2853750, and rs35893069 in the SPP1 gene and the BRC susceptibility. We used Snapshot assay to detect SPP1 single nucleotide polymorphisms in 471 BRC patients and 471 controls. The plasma SPP1 level was measured by ELISA. We found that the CC genotype and C allele of rs11730582 were associated with a significantly decreased BRC risk compared with the TT genotype and T allele, respectively [CC vs. TT: odds ratio (OR) = 0.59, 95% CI = 0.37-0.94,

Indexed as

allelebreast cancerrisksecreted phosphoprotein-1single nucleotide polymorphism

Identifiers

PMID31921672
PMCPMC6933604
OpenAlexW2989594472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.